Eversense®, the World's First and Only Long-term CGM System Is Now Covered By Medicare

The future of Continuous Glucose Monitoring (CGM) is here today.

More Focus on Life and Less on Managing Diabetes, with Features Including:

Professionally inserted sensor the fits comfortably under your skin and lasts for up to 90 days

Removable and re-attachable transmitter provides flexibility without wasting a sensor

On-body vibrations that alert you when your glucose levels are either too high or too low

An easy way to share important data automatically with your health care team

If you can answer yes to these 4 questions, you could be eligible for Eversense under Medicare!

  • Do you have diabetes?
  • Do you take insulin at least 3 times a day and/or use an insulin pump?
  • Do you currently test your blood glucose at least 4 times a day?
  • Do you visit your doctor, in person or via video, at least once every 6 months?


Get in touch to learn more about how to get started on Eversense

Please complete your contact details and an Ascensia Diabetes Care representative will follow up with you shortly. Curious about cost? Ascensia Diabetes Care can assist you in navigating your insurance coverage.

*Field is required

 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.